Sorting cells with sound waves
Acoustic device that separates tumor cells from blood cells could help assess cancer’s spread.
RNA combination therapy for lung cancer offers promise for personalized medicine
Researchers improve therapeutic response in clinically relevant model of lung-tumor growth.
New analysis reveals tumor weaknesses
Identifying epigenetic markers in cancer cells could improve patient treatment.
A new way to model cancer
New gene-editing technique allows scientists to more rapidly study the role of mutations in tumor development.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
New particle-sorting method breaks speed records
Discovery could lead to new ways of detecting cancer cells or purifying contaminated water.
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Yeast studies suggest alternative cancer approach
Biophysicist Jeff Gore and collaborators urge applying lessons from yeast colony collapse to tumor growth.
Biotech to the rescue
Ram Sasisekharan’s startups provide novel methods to fight disease and make better drugs.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Tracking oxygen in the body
MRI sensor that enables long-term monitoring of oxygen levels could aid cancer diagnosis and treatment.
Targeting cancer with a triple threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.